2014
DOI: 10.1161/circep.114.001818
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Evaluation of Pediatric Relatives in Sudden Arrhythmic Death Syndrome

Abstract: Background-Sudden arrhythmic death syndrome defines a sudden unexpected and unexplained death despite comprehensive pathological and toxicological investigation. Previous studies have focused on evaluation of adult relatives. There is, however, a lack of data in children, leading to highly variable management. We sought to determine the clinical utility of cardiac evaluation in pediatric relatives of sudden arrhythmic death syndrome probands. Methods and Results-Retrospective review was undertaken of pediatric… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0
1

Year Published

2016
2016
2017
2017

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(22 citation statements)
references
References 24 publications
1
20
0
1
Order By: Relevance
“…Identification of a VUS result should not trigger familial testing of the decedent's surviving first-degree relatives who have a normal cardiac evaluation without careful counseling. 24,25 Specifically, the family must not conclude that a request for variant-specific testing of relatives implies that the root cause has been detected. Instead, the relatives must understand that an ambiguous variant has been found and that the VUS could be reclassified potentially, for example, if the VUS was determined to be a sporadic, de novo variant.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Identification of a VUS result should not trigger familial testing of the decedent's surviving first-degree relatives who have a normal cardiac evaluation without careful counseling. 24,25 Specifically, the family must not conclude that a request for variant-specific testing of relatives implies that the root cause has been detected. Instead, the relatives must understand that an ambiguous variant has been found and that the VUS could be reclassified potentially, for example, if the VUS was determined to be a sporadic, de novo variant.…”
Section: Discussionmentioning
confidence: 99%
“…Comparison of victims with (n=7) and without (n=11) ultrarare VUS demonstrates no difference in clinical characteristics including age (14.3±4.6 and 13.5±2.3 years; P=0.65), sex (57% and 73% men; P=0.63), race (86% and 91% white; P=1.0), sudden death as the sentinel event (86% and 73%; P=1.0), and family history of cardiac events (42% and 10%; P=0. 25). Two of the decedents hosted mutations within the CALM2 gene.…”
Section: Whole-exome Molecular Autopsymentioning
confidence: 99%
“…50%) of disease in the tested population, enhancing the positive predictive value. This approach, termed cascade screening, is useful in families with known disease causing mutations and phenotypes, 134, 135 such as LQTS, as well as in cases of sudden unexplained death, 135-139 employing electrocardiographic, genetic or other techniques as appropriate. In one study employing a national registry, an average of 2.1 new cases were identified per each LQTS proband, 134 and observational studies have noted a high diagnostic yield of affected family members of victims of SCD and unexplained cardiac arrest, 137 although this has not been a uniform finding.…”
Section: Identification Of Young Patients At Risk For Scdmentioning
confidence: 99%
“…In our experience this risk was lower (2/70; 2 NSVT in 2 SCN5A carriers among 70 tests). Their use at a very young age appears questionable, however, due to the low risk of LTA in asymptomatic patients without a spontaneous type 1 ECG pattern and the potential arrhythmogenic risk and psychological impact of provocation tests 15 .…”
Section: Brugada Syndrome In Childrenmentioning
confidence: 99%